CD4 and melanoma: Indirect evidence for their positive effect comes from the observation that melanoma tumors expressing HLA-II proteins, HLA-II(+), have better prognosis than HLA-II(─) tumors [38,41], but this differential effect could also be due to the facilitation of CD8+ T cells by activated CD4+ T cells.